Follow
Anna Egorova
Anna Egorova
Research Centre of Biotechnology RAS
Verified email at fbras.ru
Title
Cited by
Cited by
Year
Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses
A Egorova, S Ekins, M Schmidtke, V Makarov
European journal of medicinal chemistry 178, 606-622, 2019
412019
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses
A Egorova, E Kazakova, B Jahn, S Ekins, V Makarov, M Schmidtke
European journal of medicinal chemistry 188, 112007, 2020
372020
Pipeline of anti‐Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities
A Egorova, M Jackson, V Gavrilyuk, V Makarov
Medicinal research reviews 41 (4), 2350-2387, 2021
352021
Small Molecules—Prospective Novel HCMV Inhibitors
E Bogner, A Egorova, V Makarov
Viruses 13 (3), 474, 2021
142021
Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review)
A Egorova, E Bogner, E Novoselova, KM Zorn, S Ekins, V Makarov
European Journal of Medicinal Chemistry 211, 113014, 2021
142021
Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)
A Egorova, EG Salina, V Makarov
International Journal of Molecular Sciences 22 (24), 13317, 2021
132021
Nitric oxide-releasing compounds for the treatment of lung infections
LR Chiarelli, G Degiacomi, A Egorova, V Makarov, MR Pasca
Drug Discovery Today 26 (2), 542-550, 2021
102021
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity
N Monakhova, J Korduláková, A Vocat, A Egorova, A Lepioshkin, ...
ACS Infectious Diseases 7 (1), 88-100, 2020
82020
WIN compounds: on the way to efficient antipicornaviral agent. A historical survey
AP Egorova, VA Makarov
Russian Chemical Bulletin 69 (4), 635-646, 2020
72020
The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
A Volobueva, A Egorova, A Galochkina, S Ekins, V Zarubaev, V Makarov
Molecules 25 (6), 1345, 2020
72020
Broad-spectrum antiviral diazadispiroalkane core molecules block attachment and cell-to-cell spread of herpesviruses
A Dohme, M Knoblauch, A Egorova, V Makarov, E Bogner
Antiviral Research 206, 105402, 2022
52022
A proof-of-concept study for the efficacy of dispirotripiperazine PDSTP in a rabbit model of herpes simplex epithelial keratitis
L Alimbarova, A Egorova, O Riabova, N Monakhova, V Makarov
Antiviral Research 202, 105327, 2022
42022
Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5
TR Lane, J Fu, B Sherry, B Tarbet, BL Hurst, O Riabova, E Kazakova, ...
Antiviral Research 216, 105654, 2023
12023
Thienopyrimidines kill Mycobacterium tuberculosis by production of nitric oxide
EG Salina, AP Egorova, LR Chiarelli, MR Pasca, VA Makarov
FEBS Open Bio 8, 239-240, 2018
12018
Molecular mechanism of rhinovirus escape from the Pyrazolo [3, 4-d] pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives …
M Richter, K Döring, D Blaas, O Riabova, M Khrenova, E Kazakova, ...
Antiviral Research 222, 105810, 2024
2024
Antidepressant-like Effect of the Eburnamine-Type Molecule Vindeburnol in Rat and Mouse Models of Ultrasound-Induced Depression
E Zubkov, O Riabova, Y Zorkina, A Egorova, V Ushakova, A Lepioshkin, ...
ACS Chemical Neuroscience 15 (3), 560-571, 2024
2024
SCRAPPY-a single cell rapid assay of proteome perturbation in yeast uncovers a joint role of aromatic amino acids and oxidative stress in the toxicity of lipophilic nucleoside …
E Ghazy, VA Bidiuk, F Ryabov, OV Mitkevich, O Riabova, ...
bioRxiv, 2024.02. 19.580949, 2024
2024
Pyrrolo [2, 3-e] indazole as a novel chemotype for both influenza A virus and pneumococcal neuraminidase inhibitors
A Egorova, M Richter, M Khrenova, E Dietrich, A Tsedilin, E Kazakova, ...
RSC advances 13 (27), 18253-18261, 2023
2023
Thieno[2,3‐d]pyrimidine‐Core Compounds Show Activity against Clinically Relevant Gram‐Positive Bacteria
O Riabova, A Egorova, A Lepioshkin, Y Li, K Voigt, F Kloss, V Makarov
ChemMedChem 17 (17), e202200207, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–19